American Century Companies’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-135,063
Closed -$1.59M 1449
2016
Q3
$1.59M Sell
135,063
-146,903
-52% -$2.23M ﹤0.01% 1094
2016
Q2
$3.65M Buy
281,966
+5,154
+2% +$75.1K ﹤0.01% 920
2016
Q1
$4.43M Buy
+276,812
New +$5.26M 0.01% 848
2015
Q3
Sell
-10,407
Closed -$374K 1465
2015
Q2
$374K Buy
+10,407
New +$324K ﹤0.01% 1260
2015
Q1
Sell
-55,450
Closed -$1.17M 1478
2014
Q4
$1.17M Sell
55,450
-151,184
-73% -$2.99M ﹤0.01% 1167
2014
Q3
$4.01M Buy
206,634
+90,828
+78% +$1.43M ﹤0.01% 930
2014
Q2
$1.81M Buy
+115,806
New +$1.87M ﹤0.01% 1117

Other funds holding INSY

American Century Companies's INSY Position: Q4 2016 in Review

American Century Companies sold out of Insys Therapeutics, Inc. (INSY) in Q4 2016, closing a stake of 135,063 shares — an estimated $1.59M sold.

American Century Companies first reported a position in INSY in Q2 2014 and held it in 7 quarters. The position peaked at $4.43M in Q1 2016. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • American Century Companies reported no remaining Insys Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • American Century Companies sold 135,063 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $1.59M.
  • American Century Companies first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 7 quarters.
  • American Century Companies's Insys Therapeutics, Inc. position peaked at $4.43M in Q1 2016.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on American Century Companies's 13F filing for Q4 2016, filed 3 Feb 2017.